Wave Life Sciences WVE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $544.59M-9.5% | $602.07M+207% | $196.22M-5.9% | $208.48M-14.2% | $243.08M-19.5% | ||
| $3.82M+0.2% | $3.81M+0.3% | $3.8M+0.3% | $3.78M+0.3% | $3.77M+0.3% | ||
| $0-100% | $1.28M-87.2% | $10M+518% | $1.62M+214% | -$1.42M-200% | ||
| $561.27M-8.7% | $614.81M+185% | $215.49M-3.6% | $223.56M-13.3% | $257.98M-19.5% | ||
| $7.08M-4.4% | $7.41M-9.7% | $8.2M-9.3% | $9.04M-5.5% | $9.57M-5.5% | ||
| $10.99M-11.8% | $12.46M-10.2% | $13.88M-9.0% | $15.25M-8.0% | $16.58M-7.2% | ||
| $386K+2,313% | $16K-27.3% | $22K-97.0% | $728K+62.5% | $448K+715% | ||
| $22.27M-6.0% | $23.69M-8.5% | $25.89M-10.1% | $28.8M-5.2% | $30.37M-4.5% | ||
| $583.54M-8.6% | $638.5M+165% | $241.38M-4.3% | $252.36M-12.5% | $288.34M-18.1% | ||
| $19.06M+21.4% | $15.7M+8.4% | $14.49M-1.2% | $14.66M+2.1% | $14.36M-11.7% | ||
| $13.04M-50.9% | $26.56M+61.1% | $16.49M+26.6% | $13.03M+66.7% | $7.81M-62.9% | ||
| $9.4M-78.9% | $44.44M-4.5% | $46.53M-9.8% | $51.58M-10.0% | $57.31M-13.1% | ||
| $8.33M-0.4% | $8.36M-0.4% | $8.39M+3.2% | $8.14M+3.2% | $7.88M+3.2% | ||
| $14.6M+87.2% | $7.8M-33.2% | $11.68M+176% | $4.23M-24.2% | $5.58M-8.4% | ||
| $49.83M-47.6% | $95.07M+10.7% | $85.9M-1.7% | $87.41M0.0% | $87.37M-21.3% | ||
| $7.39M-21.5% | $9.41M-17.3% | $11.38M-16.2% | $13.58M-13.6% | $15.72M-11.5% | ||
| $21.98M+27.8% | $17.2M-25.4% | $23.06M+29.5% | $17.81M-16.4% | $21.3M-10.8% | ||
| $71.81M-36.0% | $112.27M+3.0% | $108.96M+3.6% | $105.22M-3.2% | $108.67M-19.4% | ||
| $1.63B+0.6% | $1.62B+32.1% | $1.22B+2.7% | $1.19B+1.0% | $1.18B+0.4% | ||
| $237.43M+4.0% | $228.37M+31.2% | $174.08M+3.9% | $167.6M+3.8% | $161.41M+3.2% | ||
| -$1.35B-2.0% | -$1.33B-4.2% | -$1.27B-4.4% | -$1.22B-4.3% | -$1.17B-4.2% | ||
| -$254K-1.6% | -$250K-31.6% | -$190K-18.0% | -$161K+21.1% | -$204K+22.1% | ||
| $511.73M-1.3% | $518.36M+316% | $124.55M-10.6% | $139.27M-18.9% | $171.8M-18.0% | ||
| $583.54M-8.6% | $638.5M+165% | $241.38M-4.3% | $252.36M-12.5% | $288.34M-18.1% | ||
| $3.46M+12.4% | $3.08M+17.5% | $2.62M-61.3% | $6.76M-1.2% | $6.84M-7.0% | ||
| $386K+2,313% | $16K-27.3% | $22K— | —— | —— | ||
| $10.99M-11.8% | $12.46M-10.2% | $13.88M-9.0% | $15.25M-8.0% | $16.58M-7.2% | ||
| $10.99M-11.8% | $12.46M-10.2% | $13.88M-9.0% | $15.25M-8.0% | $16.58M-7.2% | ||
| $386K+2,313% | $16K-27.3% | $22K— | —— | —— | ||
| $10.99M-11.8% | $12.46M-10.2% | $13.88M-9.0% | $15.25M-8.0% | $16.58M-7.2% | ||
| $386K+2,313% | $16K-27.3% | $22K— | —— | —— | ||
| $14.6M+87.2% | $7.8M-33.2% | $11.68M+176% | $4.23M-24.2% | $5.58M-8.4% | ||
| $14.6M+87.2% | $7.8M-33.2% | $11.68M+176% | $4.23M-24.2% | $5.58M-8.4% | ||
| $13.04M-50.9% | $26.56M+61.1% | $16.49M+26.6% | $13.03M+66.7% | $7.81M-62.9% | ||
| $14.6M+87.2% | $7.8M-33.2% | $11.68M+176% | $4.23M-24.2% | $5.58M-8.4% | ||
| $15.72M-11.5% | $17.77M-10.1% | $19.77M-8.9% | $21.71M-8.0% | $23.6M-7.1% | ||
| $1.63B+0.6% | $1.62B+32.1% | $1.22B+2.7% | $1.19B+1.0% | $1.18B+0.4% | ||
| $13.23M+57.5% | $8.4M+26.2% | $6.65M-0.7% | $6.7M-16.9% | $8.06M-15.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Wave Life Sciences's total assets?
- Wave Life Sciences (WVE) holds $583.5M in total assets, up 102.4% year over year.
- How much debt does Wave Life Sciences have?
- Wave Life Sciences carries $15.7M in total debt against $511.7M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Wave Life Sciences have?
- Wave Life Sciences holds $544.6M in cash and equivalents.
- Can Wave Life Sciences cover its short-term obligations?
- Its current ratio is 11.26 — current assets exceed current liabilities.
- Where does Wave Life Sciences's balance sheet data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
